Toronto-based MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) agreed to sell one of its cultivation and production facilities in British Columbia to competitor Rubicon Organics (TSXV: ROMJ) (OTCQX: ROMJF) for C$4.5 million in cash, providing a capital infusion after another facility sale fell through earlier this month.
The sale of the…
Please login to read all 211 words.
